insulin icodec/semaglutide First Once-Weekly Basal Approved for Type 2 Diabetes CGM-derived postprandial glucose with IcoSema
Description
Losing weight reduces strain on your heart and improves blood pressure, blood sugar, and cholesterol levels
More similar content
This is printed on the vial or the packaging
In addition, the authors thank Novo Nordisk A/S for their contribution to the study design, data management, and data analysis, Sayeh Tadayon (Novo Nordisk) for her review and input to the manuscript, and Flavia Sciota, PhD (AXON Communications) for medical writing and editorial assistance
Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns
